使用改良的经房间隔鞘管经导管延迟取出用于持续性溶血的拉什金德动脉导管未闭封堵装置。
Late transcatheter removal of a Rashkind PDA occlusion device for persistent hemolysis using a modified transseptal sheath.
作者信息
Grifka R G, O'Laughlin M P, Mullins C E
机构信息
Baylor College of Medicine, Houston, TX.
出版信息
Cathet Cardiovasc Diagn. 1992 Feb;25(2):140-3. doi: 10.1002/ccd.1810250210.
PMID:1544155
Abstract
A patient developed hemolysis and hematuria 2 d after placement of a 12 mm Rashkind PDA occlusion device. Six days after placement, the device was snared from the ductus arteriosus and removed through a modified transseptal sheath. A 17 mm PDA occlusion device was successfully placed in the PDA, with resolution of the hematuria.
摘要
一名患者在植入12毫米Rashkind动脉导管未闭封堵器2天后出现溶血和血尿。植入后6天，该封堵器从动脉导管中圈套取出，并通过改良的经房间隔鞘管移除。一枚17毫米的动脉导管未闭封堵器成功植入动脉导管未闭处，血尿消失。
Zotero 插件